Novartis AG is 609.0x more valuable than Evotec SE by market capitalization ($283.13 B vs $464.89 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EVO | NVS |
|---|---|---|
| Market cap | $464.89 M | $283.13 B |
| US-listed rank | #2673 | #47 |
| SEC filings | 180 | 947 |
Novartis AG is 609.0x more valuable than Evotec SE by market capitalization ($283.13 B vs $464.89 M).
Full pages: Evotec SE and Novartis AG, or browse the full rankings.